Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05327946
Title A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Florida Cancer Specialists-Sarasota-61670 Sarasota Florida 34232 United States Details
John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Centre Hospitalier de l'Universite de Montreal (CHUM) Montreal Quebec H2X 0A9 Canada Details
National Cancer Center Hospital East Chiba, Kashiwa 277-8577 Japan Details
National Cancer Center Hospital Tokyo, Chuo-ku 104-0045 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field